---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-222937"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:57:06.422278+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sensei Biotherapeutics appoints Josiah Craver as principal financial officer

## Summary
- Craver appointed principal financial and accounting officer effective Sept 17, 2024; previously SVP Finance since July 2024.
- Base salary $360,000, annual bonus target 35%, and stock option for 80,000 shares vesting over 4 years.
- Severance: six months salary if terminated without cause/good reason; 12 months salary plus bonus and equity acceleration upon change in control.
- David Gaiero ceased serving as interim principal financial and accounting officer immediately.

## SEC filing metadata
- accession: 0001193125-24-222937
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312524222937/0001193125-24-222937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312524222937/d881257d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-222937
- JSON: https://secwatch.observer/filing/0001193125-24-222937.json
- Plain text: https://secwatch.observer/filing/0001193125-24-222937.txt

## Key facts
- Executive change
  David Gaiero departed as interim principal financial officer and principal accounting officer at Sensei Biotherapeutics, Inc..
  - Action: ceased serving
  - Role: interim principal financial officer and principal accounting officer
  source text: In connection with such appointment, David Gaiero, who was serving as the Company’s principal financial officer and principal accounting officer on an interim basis, ceased serving in such capacities as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312524222937/0001193125-24-222937-index.htm
- Executive change
  Josiah Craver was appointed as principal financial officer and principal accounting officer at Sensei Biotherapeutics, Inc..
  - Action: appointed
  - Role: principal financial officer and principal accounting officer
  source text: On September 17, 2024, the Board of Directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) appointed Josiah Craver as the Company’s principal financial officer and principal accounting officer, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312524222937/0001193125-24-222937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.